Cachexia is an independent predictor of mortality in patients with hepatocellular carcinoma on systemic targeted therapy
Cachexia was prevalent among patients with HCC receiving systemic targeted therapy and was identified as an independent predictor of poorer OS and PPS. Given the prognostic impact, the evaluation of cachexia is crucial in managing patients with HCC undergoing systemic targeted therapy.
Authors
- Kenji Imai (ORCID: https://orcid.org/0000-0001-5965-746X)
- Masahito Shimizu (ORCID: https://orcid.org/0000-0002-1151-2058)
- Shinji Unome (ORCID: https://orcid.org/0000-0001-6185-4796)
- Atsushi Suetsugu
- Masashi Aiba
- Takao Miwa (ORCID: https://orcid.org/0000-0002-6373-260X)
- Tatsunori Hanai (ORCID: https://orcid.org/0000-0001-7797-9534)
- Koji Takai
Institutions
- Gifu University (JP)
Publication Details
- Journal
- Clinical Nutrition ESPEN
- Published
- 2025-02-22
- DOI
- https://doi.org/10.1016/j.clnesp.2025.02.018
- Citations
- 3
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 3.49